$QBTS
D-Wave Quantum Inc. Stock $qbts

$qbts Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000190798223000043 Filed on November 09, 2023

Income Statement

Concept	2023 Q4	2023 Q3
Revenue	$2.906M	$2.562M
YoY Change	21.34%	51.15%
Cost Of Revenue	$939.0K	$1.033M
YoY Change	-11.83%	69.62%
Gross Profit	$1.967M	$1.529M
YoY Change	47.89%	40.79%
Gross Profit Margin	67.69%	59.68%
Selling, General & Admin	$10.55M	$10.48M
YoY Change	-12.49%	16.15%
% of Gross Profit	536.5%	685.22%
Research & Development	$7.956M	$9.459M
YoY Change	-22.77%	28.97%
% of Gross Profit	404.47%	618.64%
Depreciation & Amortization	$224.0K	$200.0K
YoY Change	-41.82%	-40.83%
% of Gross Profit	11.39%	13.08%
Operating Expenses	$18.51M	$19.94M
YoY Change	-17.23%	21.9%
Operating Profit	-$16.54M	-$18.41M
YoY Change	-21.34%	20.56%
Interest Expense	$1.785M	$450.0K
YoY Change	-78.23%	-66.32%
% of Operating Profit
Other Income/Expense, Net	-$1.257M	$2.578M
YoY Change	-2956.82%	16.39%
Pretax Income	-$16.01M	-$15.83M
YoY Change	25.22%	21.27%
Income Tax
% Of Pretax Income
Net Earnings	-$16.01M	-$15.80M
YoY Change	25.22%	20.61%
Net Earnings / Revenue	-551.07%	-616.71%
Basic Earnings Per Share		-$0.12
Diluted Earnings Per Share	-$0.10	-$0.12
COMMON SHARES
Basic Shares Outstanding	113.4M shares	98.90M shares
Diluted Shares Outstanding		133.2M shares

Balance Sheet

Concept	2023 Q4	2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$41.31M	$53.32M
YoY Change	484.67%	287.39%
Cash & Equivalents	$41.31M	$53.32M
Short-Term Investments
Other Short-Term Assets	$1.923M	$1.750M
YoY Change	-47.21%	-78.63%
Inventory	$2.078M	$2.244M
Prepaid Expenses
Receivables	$1.652M	$763.0K
Other Receivables	$86.00K	$130.0K
Total Short-Term Assets	$47.05M	$58.19M
YoY Change	237.85%	121.45%
LONG-TERM ASSETS
Property, Plant & Equipment	$10.77M	$1.879M
YoY Change	369.66%	-25.94%
Goodwill
YoY Change
Intangibles	$179.0K	$195.0K
YoY Change	-26.64%	-25.57%
Long-Term Investments
YoY Change
Other Assets	$1.357M	$1.351M
YoY Change	0.44%	0.45%
Total Long-Term Assets	$12.31M	$11.99M
YoY Change	-5.47%	-1.84%
TOTAL ASSETS
Total Short-Term Assets	$47.05M	$58.19M
Total Long-Term Assets	$12.31M	$11.99M
Total Assets	$59.36M	$70.18M
YoY Change	120.27%	82.34%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$6.808M	$1.540M
YoY Change	9.54%	-51.23%
Accrued Expenses	$6.672M	$9.604M
YoY Change	-0.22%	80.59%
Deferred Revenue	$2.669M	$2.177M
YoY Change	49.86%	9.45%
Short-Term Debt	$0.00	$110.0K
YoY Change	-100.0%	-73.81%
Long-Term Debt Due	$399.0K	$30.01M
YoY Change	-76.12%	1244.35%
Total Short-Term Liabilities	$11.25M	$43.33M
YoY Change	-29.01%	197.21%
LONG-TERM LIABILITIES
Long-Term Debt	$63.85M	$9.108M
YoY Change	717.44%	-29.46%
Other Long-Term Liabilities	$8.737M	$8.950M
YoY Change
Total Long-Term Liabilities	$72.59M	$9.108M
YoY Change	829.29%	-29.46%
TOTAL LIABILITIES
Total Short-Term Liabilities	$11.25M	$43.33M
Total Long-Term Liabilities	$72.59M	$9.108M
Total Liabilities	$83.84M	$61.38M
YoY Change	155.13%	56.59%
SHAREHOLDERS EQUITY
Retained Earnings	-$483.1M	-$443.1M
YoY Change	28.21%	22.03%
Common Stock	$16.00K	$15.00K
YoY Change	45.45%	36.36%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$24.48M	$8.796M
YoY Change
Total Liabilities & Shareholders Equity	$59.36M	$70.18M
YoY Change	120.27%	82.34%

Cashflow Statement

Concept	2023 Q4	2023 Q3
OPERATING ACTIVITIES
Net Income	-$16.01M	-$15.80M
YoY Change	25.22%	20.61%
Depreciation, Depletion And Amortization	$224.0K	$200.0K
YoY Change	-41.82%	-40.83%
Cash From Operating Activities	-$14.74M	-$16.87M
YoY Change	35.38%	32.1%
INVESTING ACTIVITIES
Capital Expenditures	$450.0K	$100.0K
YoY Change	147.25%	-202.04%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$450.0K	-$100.0K
YoY Change	147.25%	2.04%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	3.226M	62.75M
YoY Change	-24.94%	288.95%
NET CHANGE
Cash From Operating Activities	-14.74M	-16.87M
Cash From Investing Activities	-450.0K	-100.0K
Cash From Financing Activities	3.226M	62.75M
Net Change In Cash	-11.96M	45.78M
YoY Change	76.68%	1302.57%
FREE CASH FLOW
Cash From Operating Activities	-$14.74M	-$16.87M
Capital Expenditures	$450.0K	$100.0K
Free Cash Flow	-$15.19M	-$16.97M
YoY Change	37.22%	33.91%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	1671000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1781000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	15848000	usd
CY2022Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	1892000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	7301000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	7811000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	9000	usd
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	675000000	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	11000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	381274000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-376797000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-10402000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-5914000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	26947000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1695000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5852000	usd
	us-gaap	Gross Profit GrossProfit	2920000	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7507000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	29922000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	21799000	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5925000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	28875000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	13566000	usd
CY2022Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2773000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	7862000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	5982000	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	16205000	usd
	us-gaap	Operating Expenses OperatingExpenses	66659000	usd
	us-gaap	Operating Expenses OperatingExpenses	41347000	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-15164000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-64004000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-38427000	usd
CY2022Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-2603000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	79000	usd
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	133222318	shares
CY2022Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent
CY2023Q3	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent
CY2023Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	30006000	usd
CY2023Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2177000	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	43328000	usd
CY2023Q3	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	1971000	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	6884000	usd
CY2023Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	9108000	usd
CY2023Q3	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	92000	usd
CY2023Q3	us-gaap	Liabilities Liabilities	61383000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	32861000	usd
CY2023Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	675000000	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	155288763	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	155288763	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	113335530	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	113335530	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	15000	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	462385000	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-443132000	usd
CY2023Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-10472000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	8796000	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	70179000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2562000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4778000	usd
CY2023Q3	us-gaap	Cost Of Revenue CostOfRevenue	1033000	usd
CY2022Q3	us-gaap	Cost Of Revenue CostOfRevenue	654000	usd
	us-gaap	Gross Profit GrossProfit	2655000	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9459000	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8003000	usd
CY2023Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2474000	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	19936000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-18407000	usd
CY2023Q3	us-gaap	Interest Expense Other InterestExpenseOther	1247000	usd
CY2022Q3	us-gaap	Interest Expense Other InterestExpenseOther	1069000	usd
	us-gaap	Interest Expense Other InterestExpenseOther	2482000	usd
	us-gaap	Interest Expense Other InterestExpenseOther	3588000	usd
CY2023Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1433000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-2603000	usd
CY2023Q3	us-gaap	Government Assistance Amount GovernmentAssistanceAmount	1051000	usd
CY2022Q3	us-gaap	Government Assistance Amount GovernmentAssistanceAmount	0	usd
	us-gaap	Government Assistance Amount GovernmentAssistanceAmount	1051000	usd
	us-gaap	Government Assistance Amount GovernmentAssistanceAmount	0	usd
CY2023Q3	qbts	Equity Line Of Credit Issuance Expense EquityLineOfCreditIssuanceExpense	0	usd
CY2022Q3	qbts	Equity Line Of Credit Issuance Expense EquityLineOfCreditIssuanceExpense	629000	usd
	qbts	Equity Line Of Credit Issuance Expense EquityLineOfCreditIssuanceExpense	0	usd
	qbts	Equity Line Of Credit Issuance Expense EquityLineOfCreditIssuanceExpense	629000	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	365000	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	948000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-59000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1301000	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2578000	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1853000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2331000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-313000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-15829000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-66335000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-38740000	usd
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.12
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.11
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	133222318	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	116256805	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	116256805	shares
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-15829000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-13311000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-66335000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-38740000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	15000	usd
CY2022Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	56000	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	18000	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-15814000	usd
CY2022Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-13255000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-66405000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-38722000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-27893000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	683000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	45663000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	273000	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5884000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	15000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-15829000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	8796000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-20732000	usd
CY2022Q3	qbts	Stock Issued During Period Value Reverse Recapitalization StockIssuedDuringPeriodValueReverseRecapitalization	-16242000	usd
CY2022Q3	qbts	Stock Issued During Period Value Exercise Of Warrants StockIssuedDuringPeriodValueExerciseOfWarrants	910000	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1781000	usd
CY2022Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	56000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-13311000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-4267000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-5914000	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1890000	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	61346000	usd
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	273000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	17362000	usd
	qbts	Adjustments To Additional Paid In Capital Short Swing Profit Settlement AdjustmentsToAdditionalPaidInCapitalShortSwingProfitSettlement	244000	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-70000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-66335000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	8796000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	3020000	usd
	qbts	Stock Issued During Period Value Reverse Recapitalization StockIssuedDuringPeriodValueReverseRecapitalization	-16242000	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	141000	usd
	qbts	Stock Issued During Period Value Exercise Of Warrants StockIssuedDuringPeriodValueExerciseOfWarrants	910000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3355000	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	18000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-38740000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-4267000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-66335000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	828000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1038000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	17362000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	3355000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	573000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	493000	usd
	qbts	Noncash Interest Expense NoncashInterestExpense	2405000	usd
	qbts	Noncash Interest Expense NoncashInterestExpense	1616000	usd
	qbts	Noncash Fee Expense NoncashFeeExpense	0	usd
	qbts	Noncash Fee Expense NoncashFeeExpense	1808000	usd
	qbts	Non Cash Equity Line Of Credit Issuance Costs NonCashEquityLineOfCreditIssuanceCosts	0	usd
	qbts	Non Cash Equity Line Of Credit Issuance Costs NonCashEquityLineOfCreditIssuanceCosts	629000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	79000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-2603000	usd
	qbts	Fair Value Adjustment Of Debt Instrument FairValueAdjustmentOfDebtInstrument	-1356000	usd
	qbts	Fair Value Adjustment Of Debt Instrument FairValueAdjustmentOfDebtInstrument	0	usd
	qbts	Amortization Of Debt Issuance Costs Net AmortizationOfDebtIssuanceCostsNet	993000	usd
	qbts	Amortization Of Debt Issuance Costs Net AmortizationOfDebtIssuanceCostsNet	0	usd
	qbts	Government Assistance Noncash GovernmentAssistanceNoncash	1051000	usd
	qbts	Government Assistance Noncash GovernmentAssistanceNoncash	0	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	15000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	1226000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-35000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-266000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-7000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1000	usd
	qbts	Increase Decrease In Research Incentives Receivable IncreaseDecreaseInResearchIncentivesReceivable	0	usd
	qbts	Increase Decrease In Research Incentives Receivable IncreaseDecreaseInResearchIncentivesReceivable	-1448000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	235000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	684000	usd
	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	0	usd
	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	-1250000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-2035000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3815000	usd
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-2267000	usd
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	614000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	965000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	1704000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	479000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-1051000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-412000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-442000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-45910000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-34339000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	141000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	249000	usd
	us-gaap	Payments For Software PaymentsForSoftware	35000	usd
	us-gaap	Payments For Software PaymentsForSoftware	67000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-176000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-316000	usd
	qbts	Reverse Recapitalization Net Of Redemption And Transaction Costs ReverseRecapitalizationNetOfRedemptionAndTransactionCosts	0	usd
	qbts	Reverse Recapitalization Net Of Redemption And Transaction Costs ReverseRecapitalizationNetOfRedemptionAndTransactionCosts	4100000	usd
	qbts	Payments Of Reverse Recapitalization Transaction Costs PaymentsOfReverseRecapitalizationTransactionCosts	0	usd
	qbts	Payments Of Reverse Recapitalization Transaction Costs PaymentsOfReverseRecapitalizationTransactionCosts	6528000	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	910000	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	0	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	420000	usd
	qbts	Payments For Directors And Officers Insurance PaymentsForDirectorsAndOfficersInsurance	1449000	usd
	qbts	Payments For Directors And Officers Insurance PaymentsForDirectorsAndOfficersInsurance	864000	usd
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	273000	usd
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	0	usd
	qbts	Proceeds From Government Assistance ProceedsFromGovernmentAssistance	1487000	usd
	qbts	Proceeds From Government Assistance ProceedsFromGovernmentAssistance	3124000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1890000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	141000	usd
	us-gaap	Proceeds From Issuance Of Other Long Term Debt ProceedsFromIssuanceOfOtherLongTermDebt	29007000	usd
	us-gaap	Proceeds From Issuance Of Other Long Term Debt ProceedsFromIssuanceOfOtherLongTermDebt	19870000	usd
	us-gaap	Repayments Of Other Long Term Debt RepaymentsOfOtherLongTermDebt	390000	usd
	us-gaap	Repayments Of Other Long Term Debt RepaymentsOfOtherLongTermDebt	20000000	usd
	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	0	usd
	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	1808000	usd
	qbts	Payments Of Government Loans PaymentsOfGovernmentLoans	0	usd
	qbts	Payments Of Government Loans PaymentsOfGovernmentLoans	398000	usd
	qbts	Proceeds From Short Swing Profit Settlement ProceedsFromShortSwingProfitSettlement	244000	usd
	qbts	Proceeds From Short Swing Profit Settlement ProceedsFromShortSwingProfitSettlement	0	usd
	us-gaap	Net Income Loss NetIncomeLoss	-38700000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-45900000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	92408000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	38967000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-70000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-31000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	46252000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	4281000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7065000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9483000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	53317000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13764000	usd
	qbts	Transfer From Inventory To Property And Equipment TransferFromInventoryToPropertyAndEquipment	152000	usd
	qbts	Transfer From Inventory To Property And Equipment TransferFromInventoryToPropertyAndEquipment	0	usd
	qbts	Purchases Of Property And Equipment Included In Accounts Payable PurchasesOfPropertyAndEquipmentIncludedInAccountsPayable	53000	usd
	qbts	Purchases Of Property And Equipment Included In Accounts Payable PurchasesOfPropertyAndEquipmentIncludedInAccountsPayable	0	usd
	qbts	Directors And Officers Insurance Noncash Financing Activity DirectorsAndOfficersInsuranceNoncashFinancingActivity	0	usd
	qbts	Directors And Officers Insurance Noncash Financing Activity DirectorsAndOfficersInsuranceNoncashFinancingActivity	2893000	usd
	qbts	Warrants Issued WarrantsIssued	0	usd
	qbts	Warrants Issued WarrantsIssued	8101000	usd
	qbts	Reverse Recapitalization Noncash Financing ReverseRecapitalizationNoncashFinancing	0	usd
	qbts	Reverse Recapitalization Noncash Financing ReverseRecapitalizationNoncashFinancing	5713000	usd
	us-gaap	Stock Issued1 StockIssued1	0	usd
	us-gaap	Stock Issued1 StockIssued1	3271000	usd
	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	0	usd
	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	189871000	usd
	us-gaap	Nature Of Operations NatureOfOperations	Description of business<div style="margin-bottom:0.11pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">D-Wave Quantum Inc. ("D-Wave" or the “Company”) was incorporated under the General Corporation Law of the State of Delaware on January 24, 2022. The Company was formed for the purpose of effecting a merger between DPCM Capital, Inc. (“DPCM”), D-Wave Systems Inc. (“D-Wave Systems”), and certain other affiliated entities through a series of transactions (the “Merger”) pursuant to the definitive agreement entered into on February 7, 2022 (the “Transaction Agreement”). On August 5, 2022, in conjunction with the Merger, DPCM and D-Wave Systems became wholly-owned subsidiaries of, and are operated by, the Company. Upon the completion of the Merger, the Company succeeded to all of the operations of its predecessor, D-Wave Systems. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">D-Wave is a commercial quantum computing company that provides customers with a full suite of professional services and web-based access to its superconducting quantum computer systems and integrated software environment through its cloud service, Leap</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Historically, the Company has developed its own annealing superconducting quantum computer and associated software, and its current generation quantum system is the Advantage</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> system.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">D-Wave has three operating facilities, which it leases, in North America. These facilities are located in Burnaby, British Columbia, Richmond, British Columbia, and Palo Alto, California.</span></div>
CY2023Q3	qbts	Number Of Operating Facilities NumberOfOperatingFacilities	3	facility
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-443100000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-15800000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-66300000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-13300000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-34300000	usd
CY2023Q3	us-gaap	Cash Cash	53300000	usd
CY2023Q3	qbts	Working Capital Deficit WorkingCapitalDeficit	14900000	usd
CY2022Q2	qbts	Equity Line Of Credit Right To Sell Common Stock EquityLineOfCreditRightToSellCommonStock	150000000	usd
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q2	qbts	Equity Line Of Credit Ownership Restriction Percentage EquityLineOfCreditOwnershipRestrictionPercentage	0.099
CY2022Q2	qbts	Equity Line Of Credit Floor Stock Price EquityLineOfCreditFloorStockPrice	1.00
	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	61300000	usd
	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	39487104	shares
CY2022Q2	qbts	Equity Line Of Credit Floor Stock Price EquityLineOfCreditFloorStockPrice	1.00
CY2022Q2	qbts	Equity Line Of Credit Floor Stock Price EquityLineOfCreditFloorStockPrice	1.00
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of estimates</span></div><div style="margin-bottom:0.11pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the condensed financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, revenues and expenses and the disclosure of contingent assets and liabilities in the Company’s condensed consolidated financial statements and accompanying notes as of the date of the condensed consolidated financial statements. These estimates and assumptions are based on current facts, historical experience and various other factors believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the recording of expenses that are not readily apparent from other sources. On an ongoing basis, management evaluates its estimates as there are changes in circumstances, facts, and experience.</span></div>The Company’s accounting estimates and assumptions may change over time in response to risks and uncertainties, including uncertainty in the current economic environment due to inflation, increased interest rates, Ukraine/Russia conflict, the Israel-Hamas War, and any evolutions thereof. The change could be material in future periods. As of the date of issuance of these condensed consolidated financial statements, the Company is not aware of any specific event or circumstances that would require the Company to update estimates, judgments or revise the carrying value of any assets or liabilities. Actual results may differ from those estimates or assumptions.
CY2023Q3	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	1200000	usd
CY2022Q4	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	1200000	usd
CY2023Q3	qbts	Class Of Warrant Or Right Quoted Price ClassOfWarrantOrRightQuotedPrice	0.11
CY2023Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	17916606	shares
CY2022Q3	qbts	Scientific Research And Experimental Development Investment Tax Credit ScientificResearchAndExperimentalDevelopmentInvestmentTaxCredit	0	usd
	qbts	Scientific Research And Experimental Development Investment Tax Credit ScientificResearchAndExperimentalDevelopmentInvestmentTaxCredit	100000	usd
	qbts	Scientific Research And Experimental Development Investment Tax Credit ScientificResearchAndExperimentalDevelopmentInvestmentTaxCredit	0	usd
CY2023Q3	qbts	Scientific Research And Experimental Development Investment Tax Credit ScientificResearchAndExperimentalDevelopmentInvestmentTaxCredit	0	usd
CY2022Q3	qbts	Recapitalization Exchange Ratio RecapitalizationExchangeRatio	1.4541326
CY2022Q3	qbts	Recapitalization Exchange Ratio RecapitalizationExchangeRatio	1.4541326
CY2022Q3	qbts	Reverse Recapitalization Conversion Ratio ReverseRecapitalizationConversionRatio	1
CY2022Q3	qbts	Commitment Fee Liability CommitmentFeeLiability	2600000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2562000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1695000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2562000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1695000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5852000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4778000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5852000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4778000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2562000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1695000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5852000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4778000	usd
CY2023Q3	qbts	Accounts Receivable After Allowance For Credit Loss Excluding Unbilled Receivables Current AccountsReceivableAfterAllowanceForCreditLossExcludingUnbilledReceivablesCurrent	395000	usd
CY2022Q4	qbts	Accounts Receivable After Allowance For Credit Loss Excluding Unbilled Receivables Current AccountsReceivableAfterAllowanceForCreditLossExcludingUnbilledReceivablesCurrent	757000	usd
CY2023Q3	us-gaap	Unbilled Contracts Receivable UnbilledContractsReceivable	368000	usd
CY2022Q4	us-gaap	Unbilled Contracts Receivable UnbilledContractsReceivable	58000	usd
CY2023Q3	qbts	Accounts Receivable After Allowance For Credit Loss Current Including Unbilled Receivables AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingUnbilledReceivables	763000	usd
CY2022Q4	qbts	Accounts Receivable After Allowance For Credit Loss Current Including Unbilled Receivables AccountsReceivableAfterAllowanceForCreditLossCurrentIncludingUnbilledReceivables	815000	usd
CY2023Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2177000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1781000	usd
CY2023Q3	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	92000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	9000	usd
CY2023Q3	qbts	Contract With Customer Deposit Liability ContractWithCustomerDepositLiability	45000	usd
CY2022Q4	qbts	Contract With Customer Deposit Liability ContractWithCustomerDepositLiability	45000	usd
CY2023Q3	qbts	Contract With Customer Liability And Deposit ContractWithCustomerLiabilityAndDeposit	2314000	usd
CY2022Q4	qbts	Contract With Customer Liability And Deposit ContractWithCustomerLiabilityAndDeposit	1835000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	1790000	usd
	qbts	Contract With Customer Liability Additions ContractWithCustomerLiabilityAdditions	4353000	usd
	qbts	Contract With Customer Liability Revenue Recognized Including Opening Balance ContractWithCustomerLiabilityRevenueRecognizedIncludingOpeningBalance	3874000	usd
CY2023Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	2269000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	1800000	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	1700000	usd
CY2023Q3	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	4400000	usd
CY2023Q3	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.84
CY2023Q3	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P12M
CY2023Q3	qbts	Accrued Transaction Costs Current AccruedTransactionCostsCurrent	0	usd
CY2022Q4	qbts	Accrued Transaction Costs Current AccruedTransactionCostsCurrent	2459000	usd
CY2023Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	2642000	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1858000	usd
CY2023Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	3707000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1641000	usd
CY2023Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	993000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	233000	usd
CY2023Q3	qbts	Accrued Payroll Expenses Current AccruedPayrollExpensesCurrent	722000	usd
CY2022Q4	qbts	Accrued Payroll Expenses Current AccruedPayrollExpensesCurrent	451000	usd
CY2023Q3	qbts	Contract With Customer Deposit Liability Current ContractWithCustomerDepositLiabilityCurrent	45000	usd
CY2022Q4	qbts	Contract With Customer Deposit Liability Current ContractWithCustomerDepositLiabilityCurrent	45000	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1390000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1533000	usd
CY2023Q3	us-gaap	Notes Payable Current NotesPayableCurrent	105000	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	420000	usd
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9604000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	8640000	usd
CY2023Q3	qbts	Prepaid Services Current PrepaidServicesCurrent	377000	usd
CY2022Q4	qbts	Prepaid Services Current PrepaidServicesCurrent	391000	usd
CY2023Q3	qbts	Prepaid Software Current PrepaidSoftwareCurrent	563000	usd
CY2022Q4	qbts	Prepaid Software Current PrepaidSoftwareCurrent	559000	usd
CY2023Q3	us-gaap	Prepaid Rent PrepaidRent	182000	usd
CY2022Q4	us-gaap	Prepaid Rent PrepaidRent	96000	usd
CY2023Q3	qbts	Prepaid Commissions Current PrepaidCommissionsCurrent	87000	usd
CY2022Q4	qbts	Prepaid Commissions Current PrepaidCommissionsCurrent	268000	usd
CY2023Q3	us-gaap	Prepaid Insurance PrepaidInsurance	338000	usd
CY2022Q4	us-gaap	Prepaid Insurance PrepaidInsurance	697000	usd
CY2023Q3	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	142000	usd
CY2022Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	89000	usd
CY2023Q3	qbts	Receivable Research Incentives Current ReceivableResearchIncentivesCurrent	128000	usd
CY2022Q4	qbts	Receivable Research Incentives Current ReceivableResearchIncentivesCurrent	264000	usd
CY2023Q3	us-gaap	Deposits Assets Current DepositsAssetsCurrent	17000	usd
CY2022Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	36000	usd
CY2023Q3	qbts	Directors And Officers Insurance Current DirectorsAndOfficersInsuranceCurrent	36000	usd
CY2022Q4	qbts	Directors And Officers Insurance Current DirectorsAndOfficersInsuranceCurrent	1449000	usd
CY2023Q3	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	0	usd
CY2022Q4	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	58000	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1870000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3907000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	25729000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	25405000	usd
CY2023Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	23850000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	23111000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1879000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2294000	usd
CY2023Q3	us-gaap	Depreciation Depreciation	200000	usd
CY2022Q3	us-gaap	Depreciation Depreciation	300000	usd
	us-gaap	Depreciation Depreciation	700000	usd
	us-gaap	Depreciation Depreciation	1000000	usd
CY2023Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	30006000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	1671000	usd
CY2023Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	9108000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	7811000	usd
CY2023Q3	qbts	Equity Line Of Credit Right To Sell Common Stock Maximum Amount EquityLineOfCreditRightToSellCommonStockMaximumAmount	50000000	usd
CY2023Q3	qbts	Equity Line Of Credit Right To Sell Common Stock Maximum Amount EquityLineOfCreditRightToSellCommonStockMaximumAmount	50000000	usd
CY2023Q3	qbts	Debt Instrument Premium Payment Percentage Of Amount Prepaid From Common Stock Issuance Proceeds DebtInstrumentPremiumPaymentPercentageOfAmountPrepaidFromCommonStockIssuanceProceeds	0.10
	qbts	Class Of Warrant Or Right Exercised ClassOfWarrantOrRightExercised	0	shares
CY2023Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	17916606	shares
CY2022Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	1	shares
CY2022Q3	qbts	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Prior To Exchange Ratio ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsPriorToExchangeRatio	11.50
CY2022Q3	qbts	Recapitalization Exchange Ratio RecapitalizationExchangeRatio	1.4541326
CY2022Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	7.91
CY2022Q3	qbts	Class Of Warrant Or Right Redemption Price ClassOfWarrantOrRightRedemptionPrice	0.10
CY2022Q3	qbts	Class Of Warrant Or Right Redemption Notice Period ClassOfWarrantOrRightRedemptionNoticePeriod	P30D
CY2022Q3	qbts	Class Of Warrant Or Right Redemption Share Price Threshold Trading Days ClassOfWarrantOrRightRedemptionSharePriceThresholdTradingDays	20	day
CY2022Q3	qbts	Class Of Warrant Or Right Redemption Share Price Threshold Consecutive Trading Days ClassOfWarrantOrRightRedemptionSharePriceThresholdConsecutiveTradingDays	P30D
CY2022Q3	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	10.00
CY2022Q3	qbts	Class Of Warrant Or Right Reference Value ClassOfWarrantOrRightReferenceValue	18.00
CY2022Q3	qbts	Class Of Warrant Or Right Redemption Notice Period ClassOfWarrantOrRightRedemptionNoticePeriod	P30D
CY2022Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	1155713	shares
CY2022Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	1155713	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	15387546	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.76
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y1M13D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	8763000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	2329067	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.81
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	144000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	1019743	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	3.57
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	388956	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	2.36
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	11649780	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.66
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y3M25D
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	1618000	usd
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	9809565	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	1.24
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P7Y1M17D
CY2023Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	1438000	usd
CY2023Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	1840072	shares
CY2023Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	3.89
	qbts	Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedWeightedAverageRemainingContractualTerm	P8Y4M6D
CY2023Q3	qbts	Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIntrinsicValue	180000	usd
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	11649780	shares
CY2023Q3	qbts	Share Based Compensation Arrangement By Share Based Payment Award Options Conversion Ratio ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsConversionRatio	0.889657
CY2023Q3	qbts	Share Based Compensation Arrangement By Share Based Payment Award Options To Be Issued Upon Exercise ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsToBeIssuedUponExercise	9419509	shares
CY2023Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	5600000	usd
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	3100000	usd
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	3100000	usd
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	133222318	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	116256805	shares
CY2023Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5884000	usd
CY2022Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1781000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	17362000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3355000	usd
	us-gaap	Lease Cost LeaseCost	1100000	usd
	us-gaap	Lease Cost LeaseCost	1100000	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-15829000	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-15829000	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-13311000	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-13311000	usd
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	133222318	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	116256805	shares
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.12
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.11
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-66335000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-66335000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-38740000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-38740000	usd
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	131373959	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	131373959	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	122337727	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	122337727	shares
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.50
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.50
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.32
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.32
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	48643077	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	43981267	shares

Files In Submission

Name	View Source	Status
0001907982-23-000043-index-headers.html	Edgar Link	pending
0001907982-23-000043-index.html	Edgar Link	pending
0001907982-23-000043.txt	Edgar Link	pending
0001907982-23-000043-xbrl.zip	Edgar Link	pending
exhibit106-dxwavexwaiver20.htm	Edgar Link	pending
exhibit311-q32023.htm	Edgar Link	pending
exhibit312-q32023.htm	Edgar Link	pending
exhibit321-q32023.htm	Edgar Link	pending
exhibit322-q32023.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
qbts-20230930.htm	Edgar Link	pending
qbts-20230930.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
qbts-20230930_cal.xml	Edgar Link	unprocessable
qbts-20230930_def.xml	Edgar Link	unprocessable
qbts-20230930_lab.xml	Edgar Link	unprocessable
qbts-20230930_pre.xml	Edgar Link	unprocessable
qbts-20230930_htm.xml	Edgar Link	completed
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$QBTS
D-Wave Quantum Inc. Stock $qbts

2023 Q4 Form 10-Q Financial Statement

#000190798223000043 Filed on November 09, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$QBTS D-Wave Quantum Inc. Stock $qbts

2023 Q4 Form 10-Q Financial Statement

#000190798223000043 Filed on November 09, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$QBTS
D-Wave Quantum Inc. Stock $qbts